All in this together: collaboration in emergency prehospital care research – 29 & 30 March 2022

The 999 EMS Research Forum is a UK based partnership that bring together academics and health-care providers. The 2022 999 EMS Research Forum conference is hosted by Yorkshire Ambulance Service NHS Trust (YAS) in association with Yorkshire Ambulance Service Charity, and the National Ambulance Research Steering Group (NARSG). This will take place online on 29


GoodSAM (Smartphone Activated Medics) is an internationally recognised system which integrates a highly advanced emergency dispatching platform with an extensive network of trained first responders. The GoodSAM app works by sending an alert to all registered first-responders within a certain distance of patients having a suspected cardiac arrest. This allows registered volunteers to perform cardiopulmonary resuscitation (CPR)

Airways 2

  AIRWAYS-2 was a randomised trial comparing the clinical and cost effectiveness of the i-gel supraglottic airway device with tracheal intubation in the initial airway management of patients who have suffered an out of hospital cardiac arrest (OHCA). The primary results of study have now been published here Participating Ambulance Services: East of England Ambulance

PARAMEDIC2 Almetric Score

A Randomised Trial of Epinephrine in Out-of-Hospital Cardiac Arrest This study involving five UK ambulance services and 8014 patients investigated whether using epinephrine for out-of-hospital cardiac arrest is safe and effective.  They found that using epinephrine led to improved 30-day survival compared with a placebo.  Altmetric tracks millions of mentions of 2.8 million research outputs,


PARAMEDIC2 aimed to understand whether using adrenaline is helpful or harmful when treating someone experiencing a cardiac arrest outside of a hospital. The trial found that, after 30 days, adrenaline results in a slight increase in survival but much greater likelihood of severe disability. The results were published in August 2018 in the New England


This randomised control trial sponsored by the British Heart Foundation assessed whether transdermal glyceryl trinitrate (GTN) is beneficial to patients experiencing a stroke. The trial completed recruitment in May 2018, and the results were published in February 2019 in The Lancet (RIGHT-2); Pre-hospital treatment with GTN for patients with presumed stroke does not appear to improve